Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | May 24, 2012

Insights on Electrophysiology from Heart Rhythm 2012

 

Most advances in medicine are small and incremental, but once in a while there is a rapid leap forward that draws excitement and  provides a breath of spring air in an otherwise stagnant environment. This was the feeling at the Heart Rhythm Society (HRS) 2012 scientific sessions in Boston last week in response to two new technologies that may change the way electrophysiology is practiced. The first is Cameron Health’s subcutaneous implantable cardioverter defibrillator (S-ICD) pending final U.S. Food and Drug Administration (FDA) review. The second is a new technique called FIRM, used to clearly visualize electrical activity around rotor cores in atrial fibrillation patients to precisely guide ablations. In some cases, FIRM shortened the usual four- to six-hour ablation procedure time to just minutes.

Device-wise, the S-ICD system was a favorite and the Cameron booth was packed during much of the show. The system uses leads that are placed just under the skin under direct visualization, so there is no need for angiography and it eliminates the need for venous access, endovenous leads and cardiac lead fixation. The system was also designed to be extremely simple to use and program. Boston Scientific is working on a deal to purchase the company. If approved by the FDA later this summer, the S-ICD will be the first implantable EP device to use a subcutaneous lead system, likely the first of many devices to come. Click here to see a video or click here to read more about European trial results.

Procedurally, the FIRM technology discussed in a new EP technology session was a big topic of discussion. It offers a new way to visualize electrical activity in atrial fibrillation to more effectively and quickly ablate and terminate the arrhythmia. For more information, click here to read the story.

Perhaps because of growing interest in expanding or creating new EP programs, the HRS exhibit floor was noticeably packed with attendees, more so than other cardiology shows I’ve attended over the past couple of years.

A new study on the high malfunction rate of the Riata lead was presented at HRS, adding further concern about the lead. To watch the press conference video, click here.

I also created a video touching on some of the top trends and new technology highlighted on the expo floor of HRS. To watch the video, click here.

Finally, as healthcare marches toward total integration of all reports, imaging and waveforms into the electronic medical report, there has been increased interest in electrophysiology reporting modules. DAIC spoke to EP and IT expert Michael Mirro, M.D., who explained what hospitals should look for in these systems. To watch the video of this interview, click here.

 

Related Content

Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPor
Overlay Init